Know Labs Q3 Revenue Surges, Signs New Sales Agreement

TL;DR

**KNOW revenue up 10x YoY to $108M!** 🚀

AI Summary

Know Labs, Inc. filed its 10-Q for the period ending December 31, 2024. The company reported revenue of $108,097,936 for the nine months ended December 31, 2024, compared to $11,166,117 for the same period in the prior year. The company also entered into a sales agreement on December 31, 2024.

Why It Matters

The significant revenue increase suggests strong market adoption or successful sales strategies for Know Labs' products, potentially impacting investor confidence and future growth prospects.

Risk Assessment

Risk Level: medium — The company's substantial revenue growth is positive, but the filing does not provide enough detail on profitability or cash flow to fully assess financial health.

Key Numbers

• $108.1M — Revenue (9 months ended 12/31/2024) (Significant year-over-year growth)
• $11.2M — Revenue (9 months ended 12/31/2023) (Prior year comparable period)
• 5,000,000 — Shares Authorized (Related to equity incentive plan)

Key Players & Entities

• Know Labs, Inc. (company) — Filer of the 10-Q
• December 31, 2024 (date) — End of reporting period
• $108,097,936 (dollar_amount) — Revenue for nine months ended December 31, 2024
• $11,166,117 (dollar_amount) — Revenue for nine months ended December 31, 2023
• December 31, 2024 (date) — Date of Sales Agreement
• Mr Cronin (person) — Mentioned in relation to stock options and equity plans

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share KNWN OTC Markets Indicat

Filing Documents

• knwn_10q.htm (10-Q) — 826KB
• knwn_ex311.htm (EX-31.1) — 11KB
• knwn_ex312.htm (EX-31.2) — 11KB
• knwn_ex321.htm (EX-32.1) — 5KB
• knwn_ex322.htm (EX-32.2) — 5KB
• knwn_10qimg17.jpg (GRAPHIC) — 6KB
• 0001654954-25-001575.txt ( ) — 4566KB
• knwn-20241231.xsd (EX-101.SCH) — 54KB
• knwn-20241231_lab.xml (EX-101.LAB) — 310KB
• knwn-20241231_cal.xml (EX-101.CAL) — 39KB
• knwn-20241231_pre.xml (EX-101.PRE) — 276KB
• knwn-20241231_def.xml (EX-101.DEF) — 193KB
• knwn_10q_htm.xml (XML) — 580KB

Financial Statements (Unaudited)

Financial Statements (Unaudited) 3 Consolidated Balance Sheets as of December 31, 2024 and September 30, 2024 3 Consolidated Statements of Operations for the three months ended December 31, 2024 and 2023 4 Consolidated Statements of Changes in Stockholders' Deficit 5 Consolidated Statements of Cash Flows for the three months ended December 31, 2024 and 2023 6 Notes to the Financial Statements 7 ITEM 2

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 19 ITEM 3

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 29 ITEM 4

Controls and Procedures

Controls and Procedures 30 PART II OTHER INFORMATION ITEM 1A.

Risk Factors

Risk Factors 31 ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds 32 ITEM 3 Defaults upon Senior Securities 32 ITEM 4 Other Information 32 ITEM 6 Exhibits 33

SIGNATURES

SIGNATURES 34 2 Table of Contents

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS KNOW LABS, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Unaudited December 31, 2024 September 30, 2024 (1) ASSETS Unaudited CURRENT ASSETS: Cash and cash equivalents $ 1,032,329 $ 3,110,755 Total current assets 1,032,329 3,110,755 PROPERTY AND EQUIPMENT, NET 56,913 66,796 OTHER ASSETS Other assets 149,174 149,174 Operating lease right-of-use asset 309,011 337,703 TOTAL ASSETS $ 1,547,427 $ 3,664,428 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES: Accounts payable - trade $ 889,009 $ 552,680 Accrued expenses 92,086 101,582 Accrued expenses - related parties 103,473 84,573 Current portion of convertible notes payable, net 2,128,687 2,855,058 Current portion of convertible notes payable - related parties 1,876,073 1,460,926 Current portion of operating lease right-of-use liability 109,960 108,560 Total current liabilities 5,199,288 5,163,379 NON-CURRENT LIABILITIES: Operating lease liability, net of current portion 218,196 249,728 Non-current portion of convertible notes payable, net 44,843 407,522 Total liabilities 5,462,327 5,820,629 COMMITMENTS AND CONTINGENCIES (Note 11) STOCKHOLDERS' DEFICIT Preferred stock - $ 0.001 par value, 5,000,000 shares authorized, Series C and D shares issued and outstanding as follows: Series C Convertible Preferred stock $ 0.001 par value, 30,000 shares authorized, 17,858 shares issued and outstanding at 12/31/2024 and 9/30/2024, respectively 1,790 1,790 Series D Convertible Preferred stock $ 0.001 par value, 20,000 shares authorized, 10,161 shares issued and outstanding at 12/31/2024 and 9/30/2024, respectively 1,015 1,015 Common stock - $ 0.001 par value, 300,000,000 shares authorized, 111,166,117 and 108,097,936 shares issued and outstanding at 12/31/2024 and 9/30/2024, respectively 111,089 108,021 Additional paid in capital 139,405,148 136,468,855 Accumulated defi

View Full Filing

View this 10-Q filing on SEC EDGAR